JP Morgan Chase
HALO icon

JP Morgan Chase’s Halozyme HALO Stock Holding History

JP Morgan Chase’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-35,000
Closed -$590K – 5824
2019
Q2 		$590K Buy
35,000
+5,000
+17% +$80.7K ﹤0.01% 4159
2019
Q1 		$483K Hold
30,000
– – ﹤0.01% 4223
2018
Q4 		$439K Buy
+30,000
New +$479K ﹤0.01% 4199
2018
Q1 		– Sell
-100,000
Closed -$2.03M – 5483
2017
Q4 		$2.03M Buy
+100,000
New +$1.84M ﹤0.01% 3316

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

JP Morgan Chase's HALO Position: Q2 2026 in Review

JP Morgan Chase reduced its Halozyme (HALO) stake by 23% in Q2 2026, selling an estimated $10.1M and leaving 485,922 shares worth $37.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1680.

JP Morgan Chase first reported a position in HALO in Q2 2013 and has held it in 53 quarters since. The position peaked at $239M in Q2 2021. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • JP Morgan Chase held 485,922 shares of Halozyme worth $37.9M as of Q2 2026.
  • JP Morgan Chase sold 147,808 Halozyme shares in Q2 2026, an estimated $10.1M.
  • Halozyme made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1680 holding.
  • JP Morgan Chase first reported a position in Halozyme in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Halozyme position peaked at $239M in Q2 2021.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.